Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00183378 · ClinicalTrials.gov registry record · NA

Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
132
Enrollment target

NCT00183378: Completed NA study, sponsored by University of Washington.

NCT00183378 is a NA study that has completed, run by University of Washington. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00183378, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
132 participants
Enrollment target

Study Summary

This study will compare four different behavioral treatment programs to determine which is most effective in reducing night-time disturbances in individuals with Alzheimer's disease (AD).

Interventions

  • BEHAVIORAL Walking Program
  • BEHAVIORAL Light Exposure Program
  • BEHAVIORAL Combined Education, Walking and Light Exposure Program
  • BEHAVIORAL Routine Medical Care with Education

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2005-09
Est. Completion 2011-03
Phase NA
University of Washington

1,048 total trials

What the finished NCT00183378 record still lists

NCT00183378 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 4 interventions - of which Walking Program is the first listed.

NCT00183378 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00183378 about?

NCT00183378 is a clinical study titled "Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease". This study will compare four different behavioral treatment programs to determine which is most effective in reducing night-time disturbances in individuals with Alzheimer's disease (AD).

What is the current status of trial NCT00183378?

This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2005-09. Estimated completion is 2011-03.

What interventions are being tested in trial NCT00183378?

The interventions under investigation include: Walking Program (BEHAVIORAL), Light Exposure Program (BEHAVIORAL), Combined Education, Walking and Light Exposure Program (BEHAVIORAL), Routine Medical Care with Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT00183378?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00183378's enrollment target sits among peer trials

132 729th of 2000 higher than 1,269 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01766297 · 132 participants · Phase 2

    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • NCT04002947 · 132 participants · Phase 2

    Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

  • NCT04128189 · 132 participants · Phase 3

    Shingrix in Renal Transplant Recipients

  • NCT04199780 · 132 participants · NA

    Effects of tDCS Combined With CBI on Postsurgical Pain

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00183378, the US trial registry maintained by the National Library of Medicine. NCT00183378 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.